Literature DB >> 28446039

Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.

Linus Aronsson1, Roland Andersson1, Daniel Ansari1.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is one of the most common cystic neoplasms of the pancreas. It is a heterogeneous disease and can be divided into ductal types and morphological subtypes. The incidence of IPMN is increasing, likely due to the widespread use of cross-sectional imaging and a growing elderly population. IPMN poses an increasing demand on the health care system. Current guidelines provide indications for surgery and recommendations for surveillance, but management of IPMN is still challenging in routine clinical practice. In this article, we review current knowledge about IPMN and provide future directions for improving diagnosis and management.

Entities:  

Keywords:  IPMN; diagnosis; epidemiology; pathogenesis; risk factors; treatment

Mesh:

Year:  2017        PMID: 28446039     DOI: 10.1080/00365521.2017.1318948

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Predictors, Patterns, and Timing of Recurrence Provide Insight into the Disease Biology of Invasive Carcinomas Arising in Association with Intraductal Papillary Mucinous Neoplasms.

Authors:  Joseph R Habib; Benedict Kinny-Köster; Neda Amini; Sami Shoucair; John L Cameron; Elizabeth D Thompson; Elliot K Fishman; Ralph H Hruban; Ammar A Javed; Jin He; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2022-08-01       Impact factor: 3.267

2.  A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series.

Authors:  Alexis Litchinko; Kosuke Kobayashi; Nermin Halkic
Journal:  Ann Med Surg (Lond)       Date:  2020-10-20

3.  Editorial: Management of the Small Asymptomatic Pancreatic Cyst: Somehow Along the Way We Forgot About the Patient.

Authors:  C Mel Wilcox
Journal:  Am J Gastroenterol       Date:  2017-08       Impact factor: 10.864

4.  A mixed-type intraductal papillary mucinous neoplasm of the pancreas with a histologic combination of gastric and pancreatobiliary subtypes in a 70-year-old woman: a case report.

Authors:  Sawsan Ismail; Rama Darwisho; Mohammed Ali; Maen Haidar; Mohammad Adib Houreih; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2020-09-09

5.  Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.

Authors:  Rogier Aäron Gaiser; Asif Halimi; Hassan Alkharaan; Liyan Lu; Haleh Davanian; Katie Healy; Luisa W Hugerth; Zeeshan Ateeb; Roberto Valente; Carlos Fernández Moro; Marco Del Chiaro; Margaret Sällberg Chen
Journal:  Gut       Date:  2019-03-14       Impact factor: 23.059

6.  Intraductal papillary-mucinous carcinoma with portal vein tumor thrombus and multifocal liver metastasis: An autopsy case.

Authors:  Naohiro Matsushita; Akitoshi Douhara; Hirotsugu Ueno; Shohei Asada; Koji Murata; Koji Yanase; Masahiro Tsutsumi
Journal:  Mol Clin Oncol       Date:  2021-03-13

Review 7.  A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.

Authors:  Nabeel Merali; Tarak Chouari; Kayani Kayani; Charles J Rayner; José I Jiménez; Jonathan Krell; Elisa Giovannetti; Izhar Bagwan; Kate Relph; Timothy A Rockall; Tony Dhillon; Hardev Pandha; Nicola E Annels; Adam E Frampton
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

8.  Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy.

Authors:  Hassan Alkharaan; Liyan Lu; Giorgio Gabarrini; Asif Halimi; Zeeshan Ateeb; Michał J Sobkowiak; Haleh Davanian; Carlos Fernández Moro; Leif Jansson; Marco Del Chiaro; Volkan Özenci; Margaret Sällberg Chen
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

Review 9.  Human Gut Microbiota in Health and Selected Cancers.

Authors:  Aleksandra Sędzikowska; Leszek Szablewski
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.